Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Smith

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Plos Pathogens|February 14, 2022
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Katie E Lineburg, Jyothy Raju, et al.
Plos Genetics|February 15, 2013
Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2Wei Shi, Amanda L Bain, Bjoern Schwer, et al.
Nature Communications|October 27, 2022
Ablation of CD8<sup>+</sup> T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3Srividhya Swaminathan, Katie E Lineburg, Archana Panikkar, et al.
Microbiology Spectrum|February 24, 2022
Limited Recognition of Highly Conserved Regions of SARS-CoV-2Srividhya Swaminathan, Katie E Lineburg, George R Ambalathingal, et al.
The Journal of Physiology|February 15, 2026
Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuronNi Li, Chenchen Zhang, Mengying Xu, et al.
Oncoimmunology|March 28, 2017
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical responseCorey Smith, Victor Lee, Andrea Schuessler, et al.
Cellular & Molecular Immunology|February 5, 2025
Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activationNgar-Woon Kam, Cho Yiu Lau, Jeffrey Yan Ho Lau, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Clinical & Translational Immunology|December 5, 2023
Elevated BMI reduces the humoral response to SARS-CoV-2 infectionMarcus Zw Tong, Julian Dj Sng, Meagan Carney, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Plos Pathogens|February 14, 2022
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Katie E Lineburg, Jyothy Raju, et al.
Plos Genetics|February 15, 2013
Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2Wei Shi, Amanda L Bain, Bjoern Schwer, et al.
Nature Communications|October 27, 2022
Ablation of CD8<sup>+</sup> T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3Srividhya Swaminathan, Katie E Lineburg, Archana Panikkar, et al.
Microbiology Spectrum|February 24, 2022
Limited Recognition of Highly Conserved Regions of SARS-CoV-2Srividhya Swaminathan, Katie E Lineburg, George R Ambalathingal, et al.
The Journal of Physiology|February 15, 2026
Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuronNi Li, Chenchen Zhang, Mengying Xu, et al.
Oncoimmunology|March 28, 2017
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical responseCorey Smith, Victor Lee, Andrea Schuessler, et al.
Cellular & Molecular Immunology|February 5, 2025
Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activationNgar-Woon Kam, Cho Yiu Lau, Jeffrey Yan Ho Lau, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Clinical & Translational Immunology|December 5, 2023
Elevated BMI reduces the humoral response to SARS-CoV-2 infectionMarcus Zw Tong, Julian Dj Sng, Meagan Carney, et al.
Pageof 17